-
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
prnewswire
June 15, 2021
Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint.
-
FDA Approves Prevnar 20 (pneumococcal 20-valent conjugate vaccine) for Adults Ages 18 Years or Older
firstwordpharma
June 11, 2021
Pfizer Inc. (NYSE:PFE) announced today that FDA has approved Prevnar 20™ (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae serotypes in the vaccine.
-
Pfizer cuts Norway's COVID-19 vaccine deliveries, rollout delayed
firstwordpharma
June 11, 2021
July deliveries of Pfizer’s COVID-19 vaccine to Norway have been cut by 400,000 doses, delaying the country’s vaccine rollout, the company and the Norwegian Institute of Public Health (FHI) said on Thursday, as reported by This is Money.
-
U.S. says it will push COVID vaccine waivers, but 'may take time'
firstwordpharma
June 11, 2021
US Trade Representative Katherine Tai said the Biden administration is committed to efforts to waive intellectual property rights for COVID-19 vaccines and will raise the issue with the World Trade Organization (WTO)
-
Vaccinated Adults Helps Protect Unvaccinated Children, Study Finds
firstwordpharma
June 11, 2021
New data from Israel, which had the fastest COVID-19 vaccine rollout in the world, provides real-world evidence that widespread vaccination against the coronavirus can also protect people who are unvaccinated, reported The New York Times.
-
G7 to donate 1 billion COVID-19 vaccine doses to poorer countries
firstwordpharma
June 11, 2021
UK Prime Minister Boris Johnson expects G7 leaders to agree to donate 1 billion COVID-19 vaccine doses to poorer countries during its summit starting on Friday, and help innoculate the world by the end of next year, as reported in Yahoo!News.
-
U.S. to Send 500 Million COVID-19 Vaccine Doses to Countries Desperate for Shots
drugs
June 11, 2021
The United States plans to purchase 500 million doses of Pfizer's coronavirus vaccine that it will then donate to countries in need around the world.
-
$5.1 Billion Effort to Eradicate Polio Announced
drugs
June 11, 2021
A $5.1 billion plan to eradicate polio worldwide by 2026 was announced this week by the Global Polio Eradication Initiative, a public-private partnership led by national governments and health groups.
-
Calyx Supports over 100 COVID-19 Vaccine Authorizations
prnewswire
June 11, 2021
Calyx, the eClinical and Regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced it has reached a milestone in its support of global COVID-19 vaccine authorizations.
-
With doses at risk of expiration in some states, J&J says it's working to extend the shelf-life of its Covid-19 vaccine
firstwordpharma
June 10, 2021
As some US states warn they have Johnson & Johnson COVID-19 vaccine doses that are expiring before they get used, the company and federal officials are looking at whether expiration dates can be extended, reported CNN.